$RHT nice breakout above trendlineNot enough volume to have conviction, but supply has dwindled. Im expecting news off this setup.
Resonance Health Ltd
No trades
Market insights
$RHT sollid 1/4 out and breaking the downtrend on volume.A solid newsflow and some proactive marketing by the company during February and this thing tests the 28 high. See if they can deliver.
$RHT yuge volume break of 24. 29 next critical level.After holding the buyable gap up, nice to see volume come in today. Now needs to take out the 29 open. On volume of course.
$RHT update. nice close and held the bgu on vol.Really nice progress Friday afternoon. Held the bgu low, on volume. A close around 28 would confirm this is the real deal and wants significantly higher. FDA approved tech. Now for some deals.
RHTthere's a lot to like about RHT with the recent Vol spikes on upward SP movements ...
pushing off key FIB level...
plenty of support down @ 0.145 ...
new low at 0.165 is the key now
RHT consolidatingInteresting company, pulled back to the MAs
It's a spec so high risk. Market cap around $30m
Has $2m cash so shouldn't need to raise soon
$RHT - Resonance Health ticking boxes.Resonance Health (RHT:ASX)
Interesting small cap generating some revenue. Has broken through some previous resistance levels and resuming its climb. I like the idea of "quantitative analysis of radiological images" and hope they can expand it in the future to other areas of the body.
They have been ticking off R&D grants, FDA approvals, and more redistributor agreements. Company seems to have some good momentum at the moment. Don't forget to set your stops though.
Resonance Health Limited is principally engaged in the development and commercialization of technologies and services for the quantitative analysis of radiological images. The Company's segments include Services, Research and Development, and Corporate. The Company's core product is FerriScan, which is a non-invasive liver diagnostic technology used for the measurement of iron in the liver. FerriScan is used for liver iron concentration (LIC) measurement from magnetic resonance imaging (MRI) scans of a patient's liver. The FerriScan analysis procedure produces a mean LIC measurement and a color coded map reflecting the iron distribution across the liver. The Company's product HepaFat-Scan, is a non-invasive method for measuring volumetric liver fat fraction (VLFF) from MRI scans. HepaFat-Scan is provided as an image analysis service. HepaFat-Scan is available for routine clinical use and for use in pharmaceutical company clinical trials.
